Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 1.79MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
Sector
Industry
History
$ 0.2Close
$ 0.04 - $ 0.84 52-Week Range
Ticker Information
Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADAPTIMMUNE THERAPEUTICS PLC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADAP - CF - Equity Historical data
| Date | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|
| 6/30/2025 | $ 1.79M |
| 3/31/2025 | $ 145K |
| 12/31/2024 | $ 29.25M |
| 9/30/2024 | $ 29.32M |
| 6/30/2024 | $ 29.92M |
| 3/31/2024 | $ 29.92M |
| 12/31/2023 | $ 880K |
| 9/30/2023 | $ 2.21M |
| 6/30/2023 | $ 3.06M |
| 3/31/2023 | $ 13.03M |
Key Performance Insights, Last 5 Years
- ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) CF - Equity stands at $ 339.93M.
- Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average CF - Equity has been $ 55.82M.
- The median CF - Equity for ADAPTIMMUNE THERAPEUTICS PLC during this period was $ 10.86M
- ADAPTIMMUNE THERAPEUTICS PLC reached its highest CF - Equity over the past 5 years at $ 340.05M.
- The lowest CF - Equity recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe $ 145K
ADAPTIMMUNE THERAPEUTICS PLC's CF - Equity vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Equity Benchmarks
Similar metrics to CF - Equity:
- Net Cash Flow - Issuance (Repayment) of Debt Securities - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Net Cash Flow - Dividends & Other Cash Distributions - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing dividends and dividend equivalents paid on common stock and restricted stock units.
- Buyback Yield - [Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
- Net Cash Flow - Business Acquisitions and Disposals - [Cash Flow Statement] A component of cash flow from investing [NCFI], representing the net amount of cash to acquire (outflow) or dispose (inflow) businesses, join-ventures, affiliates or other investments.
Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares
[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).ADAP - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years
$ 145K
Minimum
Mar 31, 2025
$ 340.05M
Maximum
Dec 31, 2020
$ 55.82M
Average
$ 10.86M
Median
CF - Equity Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
| filtered constituents | 2.9K |
|---|---|
| min | $ -60.59M |
| max | $ 60.64M |
| average | $ 124.49K |
| median | $ 0 |
| std | $ 17.66M |